Comment on "Costs and consequences of cardiovascular toxicity due to Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia”

Swarupanjali Padhi, Prashant Ramdas Kokiwar, Janvi Patel

Open source

DOI
10.1016/j.repc.2026.06.009
Published
2026-11
Container
Revista Portuguesa de Cardiologia
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.repc.2026.06.009,
  title = {Comment on "Costs and consequences of cardiovascular toxicity due to Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia”},
  author = {Swarupanjali Padhi and Prashant Ramdas Kokiwar and Janvi Patel},
  year = {2026},
  journal = {Revista Portuguesa de Cardiologia},
  doi = {10.1016/j.repc.2026.06.009},
  url = {https://doi.org/10.1016/j.repc.2026.06.009}
}

RIS

TY  - JOUR
TI  - Comment on "Costs and consequences of cardiovascular toxicity due to Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia”
AU  - Swarupanjali Padhi
AU  - Prashant Ramdas Kokiwar
AU  - Janvi Patel
PY  - 2026
JO  - Revista Portuguesa de Cardiologia
DO  - 10.1016/j.repc.2026.06.009
UR  - https://doi.org/10.1016/j.repc.2026.06.009
ER  - 

APA

Padhi, S., Kokiwar, P. R., & Patel, J. (2026). Comment on "Costs and consequences of cardiovascular toxicity due to Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia”. Revista Portuguesa de Cardiologia. https://doi.org/10.1016/j.repc.2026.06.009

Source records